Molecular diagnostics is a broad term describing a class of diagnostic tests that assess a person's health literally at a molecular level, detecting and measuring specific genetic sequences in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) or the proteins they express.

By using a molecular syndromic approach and a broad test menu, we can better detect and identify the infectious agent with just one easy diagnostic test. Advanta's infectious disease testing increases the probability of identifying a pathogen in patients with symptoms of an infectious disease and increases the capability of detection of co-infections.

The Women's Health menu was designed to serve the OB/GYN practitioner. Advanta's menu includes all relevant tests in women's health, including conventional Pap tests to molecular diagnostic testing for infectious diseases.

While we test individual genes, the real benefit of pharmacogenomics lies in the interplay between multiple genes and multiple drugs. Advanta's drug sensitivity panel identifies patients susceptible to adverse events and red-flags drug interations that complicate the patient's care.

Toxicology screens are used to identify substances affecting a patient and to guide the clinician to predict future toxic effects, to confirm the differential diagnosis or to guide therapy.

We provide a whole array of laboratory services, with both accuracy and speed which are vital for this type of data, upon which so many treatment decisions are based.